Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AKBA
EPRX
Add up to 3 more stocks
AKBA
Akebia Therapeutics, Inc.
-3.00%
$0.88-0.03Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$236.93M
52W Range
$0.81 - $3.20
EPRX
Eupraxia Pharmaceuticals Inc.
+0.45%
$7.78+0.04Delayed quote: Oct 6, 2026, 10:50 AM EDT
Market Cap
$260.47M
52W Range
$5.25 - $9.32
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 9.47 | 2.56 |
| P/S Ratio | 1.08 | N/A |
| P/FCF Ratio | 5.90 | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.5% | 0.0% |
| Operating Margin | 9.9% | 0.0% |
| Net Margin | -13.5% | 0.0% |
| ROE | -118.6% | -38.3% |
| ROA | -8.5% | -36.0% |
| ROIC | -7.1% | -43.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.43 | 16.00 |
| Quick Ratio | 1.35 | 16.00 |
| Debt/Equity | 2.16 | 0.01 |
| Interest Coverage | 0.97 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.